Annual Report 2025: where innovation meets application

Scientific innovation only creates value when it finds its way into practice. In 2025, CHDR focused on exactly that intersection: where new ideas are tested, refined, and ultimately applied to advance early-phase drug development. Throughout the year, we worked to bridge discovery and decision-making by combining rigorous science with practical implementation in a clinical research setting.

This Annual Report reflects how innovation and application come together in our daily work. It showcases how new study designs, digital tools, biomarkers, and translational models are not developed in isolation, but are actively embedded in clinical studies to generate actionable insights. Across a wide range of therapeutic areas, these efforts support faster, better-informed development pathways for new drugs and vaccines.

The theme Where Innovation Meets Application is woven through the stories in this report. They highlight how CHDR’s strategic focus on developing drugs, developing methods, and developing people translates into tangible outcomes, both within our organisation and in collaboration with partners across academia, biotech, and the pharmaceutical industry. By combining scientific creativity with operational excellence, we continue to strengthen our role as a translational partner in early clinical research.

We invite you to explore this report as a reflection of a year in which ideas were not only generated, but put into practice.